EcoDrugPlus

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSSARG00000006787
Gene Symbol: ADH5
1 External references
406 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSSARG00000009617
Gene Symbol: AOC1
1 External references
230 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSSARG00000008486
Gene Symbol: AOC3
3 External references
324 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSARG00000005970
Gene Symbol: AR
1 External references
277 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSSARG00000011040
Gene Symbol: APH1A
1 External references
137 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSSARG00000014021
Gene Symbol: ALOX12
3 External references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSSARG00000009667
Gene Symbol: ALOX5
1 External references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSSARG00000000102
Gene Symbol: ALOX5AP
1 External references
200 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSARG00000008266
Gene Symbol: AVPR2
3 External references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSSARG00000001961
Gene Symbol: AHR
1 External references
154 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSSARG00000005747
Gene Symbol: AURKB
3 External references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSSARG00000006840
Gene Symbol: BACE1
1 External references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).